Bath & Body Works Reports Second Quarter 2024 Results
| BATH & BODY WORKS, INC. | |||||||||||||||
| CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||
| (Unaudited) | |||||||||||||||
| (In millions, except per share amounts) | |||||||||||||||
| Second Quarter | Year-to-Date | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Net Sales | $ | 1,526 | $ | 1,559 | $ | 2,910 | $ | 2,955 | |||||||
| Costs of Goods Sold, Buying and Occupancy | (900 | ) | (937 | ) | (1,677 | ) | (1,737 | ) | |||||||
| Gross Profit | 626 | 622 | 1,233 | 1,218 | |||||||||||
| General, Administrative and Store Operating Expenses | (443 | ) | (434 | ) | (863 | ) | (849 | ) | |||||||
| Operating Income | 183 | 188 | 370 | 369 | |||||||||||
| Interest Expense | (77 | ) | (86 | ) | (159 | ) | (175 | ) | |||||||
| Other Income | 47 | 25 | 61 | 45 | |||||||||||
| Income Before Income Taxes | 153 | 127 | 272 | 239 | |||||||||||
| Provision for Income Taxes | 1 | 28 | 33 | 59 | |||||||||||
| Net Income | $ | 152 | $ | 99 | $ | 239 | $ | 180 | |||||||
| Net Income per Diluted Share | $ | 0.68 | $ | 0.43 | $ | 1.06 | $ | 0.78 | |||||||
| Weighted Average Diluted Shares Outstanding | 223 | 229 | 225 | 230 |
| BATH & BODY WORKS, INC. CONSOLIDATED CONDENSED BALANCE SHEETS (Unaudited) (In millions) | |||||||
| August 3, 2024 | July 29, 2023 | ||||||
| ASSETS | |||||||
| Current Assets: | |||||||
| Cash and Cash Equivalents | $ | 514 | $ | 790 | |||
| Accounts Receivable, Net | 146 | 153 | |||||
| Inventories | 863 | 818 | |||||
| Other | 143 | 132 | |||||
| Total Current Assets | 1,666 | 1,893 | |||||
| Property and Equipment, Net | 1,166 | 1,236 | |||||
| Operating Lease Assets | 1,043 | 1,080 | |||||
| Goodwill | 628 | 628 | |||||
| Trade Name | 165 | 165 | |||||
| Deferred Income Taxes | 143 | 38 | |||||
| Other Assets | 137 | 155 | |||||
| Total Assets | $ | 4,948 | $ | 5,195 | |||
| LIABILITIES AND EQUITY (DEFICIT) | |||||||
| Current Liabilities: | |||||||
| Accounts Payable | $ | 411 | $ | 508 | |||
| Accrued Expenses and Other | 526 | 518 | |||||
| Current Debt | 313 | - | |||||
| Current Operating Lease Liabilities | 186 | 187 | |||||
| Income Taxes | 61 | - | |||||
| Total Current Liabilities | 1,497 | 1,213 | |||||
| Deferred Income Taxes | 45 | 168 | |||||
| Long-term Debt | 3,881 | 4,668 | |||||
| Long-term Operating Lease Liabilities | 984 | 1,036 | |||||
| Other Long-term Liabilities | 259 | 264 | |||||
| Total Equity (Deficit) | (1,718 | ) | (2,154 | ) | |||
| Total Liabilities and Equity (Deficit) | $ | 4,948 | $ | 5,195 |
| BATH & BODY WORKS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (In millions) | |||||||
| Year-to-Date | |||||||
| 2024 | 2023 | ||||||
| Operating Activities: | |||||||
| Net Income | $ | 239 | $ | 180 | |||
| Adjustments to Reconcile Net Income to Net Cash Provided by Operating Activities: | |||||||
| Depreciation of Long-lived Assets | 142 | 129 | |||||
| Share-based Compensation Expense | 22 | 18 | |||||
| Gain on Sales of Easton Investments | (39 | ) | - | ||||
| Loss (Gain) on Extinguishment of Debt | 3 | (16 | ) | ||||
| Deferred Income Taxes | (102 | ) | - | ||||
| Changes in Assets and Liabilities: | |||||||
| Accounts Receivable | 78 | 74 | |||||
| Inventories | (154 | ) | (109 | ) | |||
| Accounts Payable, Accrued Expenses and Other | (67 | ) | (87 | ) | |||
| Income Taxes Payable | (79 | ) | (107 | ) | |||
| Other Assets and Liabilities | (13 | ) | (5 | ) | |||
| Net Cash Provided by Operating Activities | 30 | 77 | |||||
| Investing Activities: | |||||||
| Capital Expenditures | (101 | ) | (178 | ) | |||
| Proceeds from Sales of Easton Investments | 50 | - | |||||
| Other Investing Activities | 11 | 2 | |||||
| Net Cash Used for Investing Activities | (40 | ) | (176 | ) | |||
| Financing Activities: | |||||||
| Payments for Long-term Debt | (202 | ) | (182 | ) | |||
| Repurchases of Common Stock | (248 | ) | (48 | ) | |||
| Dividends Paid | (90 | ) | (92 | ) | |||
| Tax Payments related to Share-based Awards | (15 | ) | (9 | ) | |||
| Other Financing Activities | (5 | ) | (12 | ) | |||
| Net Cash Used for Financing Activities | (560 | ) | (343 | ) | |||
| Net Decrease in Cash and Cash Equivalents | (570 | ) | (442 | ) | |||
| Cash and Cash Equivalents, Beginning of Year | 1,084 | 1,232 | |||||
| Cash and Cash Equivalents, End of Period | $ | 514 | $ | 790 |
| BATH & BODY WORKS, INC. | |||||||||||||||
| ADJUSTED FINANCIAL INFORMATION | |||||||||||||||
| (Unaudited) | |||||||||||||||
| (In millions, except per share amounts) | |||||||||||||||
| Second Quarter | Year-to-Date | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Reconciliation of Reported Net Income to Adjusted Net Income | |||||||||||||||
| Reported Net Income | $ | 152 | $ | 99 | $ | 239 | $ | 180 | |||||||
| Gain on Sales of Easton Investments | (39 | ) | - | (39 | ) | - | |||||||||
| Gain on Extinguishment of Debt | - | (9 | ) | - | (16 | ) | |||||||||
| Tax Effect of Adjustments included in Other Income | 14 | 2 | 14 | 4 | |||||||||||
| Tax Benefit from Valuation Allowance Release | (44 | ) | - | (44 | ) | - | |||||||||
| Adjusted Net Income | $ | 83 | $ | 92 | $ | 170 | $ | 168 | |||||||
| Reconciliation of Reported Net Income Per Diluted Share to Adjusted Net Income Per Diluted Share | |||||||||||||||
| Reported Net Income Per Diluted Share | $ | 0.68 | $ | 0.43 | $ | 1.06 | $ | 0.78 | |||||||
| Gain on Sales of Easton Investments | (0.18 | ) | - | (0.18 | ) | - | |||||||||
| Gain on Extinguishment of Debt | - | (0.04 | ) | - | (0.07 | ) | |||||||||
| Tax Effect of Adjustments included in Other Income | 0.06 | 0.01 | 0.06 | 0.02 | |||||||||||
| Tax Benefit from Valuation Allowance Release | (0.20 | ) | - | (0.19 | ) | - | |||||||||
| Adjusted Net Income Per Diluted Share | $ | 0.37 | $ | 0.40 | $ | 0.76 | $ | 0.73 |
See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.
| BATH & BODY WORKS, INC. | |||||||
| ADJUSTED FORECASTED FINANCIAL INFORMATION | |||||||
| (Unaudited) | |||||||
| Full-Year | |||||||
| 2024 | |||||||
| Reconciliation of Forecasted Net Income Per Diluted Share to Adjusted Forecasted Net Income Per Diluted Share | |||||||
| Low | High | ||||||
| Forecasted Net Income Per Diluted Share | $ | 3.37 | $ | 3.57 | |||
| Gain on Sales of Easton Investments, Net of Tax | (0.11 | ) | (0.11 | ) | |||
| Tax Benefit from Valuation Allowance Release | (0.20 | ) | (0.20 | ) | |||
| Adjusted Forecasted Net Income Per Diluted Share | $ | 3.06 | $ | 3.26 |
See Notes to Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures.
BATH & BODY WORKS, INC.
NOTES TO RECONCILIATION OF GAAP FINANCIAL MEASURES
TO NON-GAAP FINANCIAL MEASURES
(Unaudited)
The“Adjusted Financial Information” provided in the attached reflects the following non-GAAP financial measures:
Fiscal 2024
In the second quarter of 2024, adjusted results excludes the following:
- A $39 million aggregate pre-tax gain ($25 million net of tax of $14 million), included in other income, related to the sales of certain Easton investments. A $44 million tax benefit related to the release of a valuation allowance on a deferred tax asset.
There were no adjustments to results in the first quarter of 2024.
Adjusted forecasted full-year 2024 Net Income per Diluted Share excludes the adjustments referenced above.
Fiscal 2023
In the second quarter of 2023, adjusted results exclude a:
- $9 million pre-tax gain ($7 million net of tax of $2 million), included in other income, associated with the early extinguishment of outstanding notes.
In the first quarter of 2023, adjusted results exclude a:
- $7 million pre-tax gain ($5 million net of tax of $2 million), included in other income, associated with the early extinguishment of outstanding notes.
The adjusted financial information should not be construed as an alternative to the results determined in accordance with generally accepted accounting principles. Further, the company's definitions of adjusted income information may differ from similarly titled measures used by other companies. Management believes that the presentation of adjusted financial information provides additional information to investors to facilitate the comparison of past and present operations. While it is not possible to predict future results, management believes the adjusted financial information is useful for the assessment of the operations of the company because the adjusted items are not indicative of the company's ongoing operations due to their size and nature. Additionally, management uses adjusted financial information as key performance measures for the purpose of evaluating performance internally. The adjusted financial information should be read in conjunction with the company's historical financial statements and notes thereto contained in the company's Quarterly Reports on Form 10-Q and Annual Report on Form 10-K.
BATH & BODY WORKS, INC.
Second Quarter 2024
Total Sales (In millions):
| Second Quarter | Year-to-Date | ||||||||||||||||||||
| 2024 | 2023 | % Change | 2024 | 2023 | % Change | ||||||||||||||||
| Stores - U.S. and Canada (a) | $ | 1,140 | $ | 1,144 | (0.3 | %) | $ | 2,205 | $ | 2,177 | 1.3 | % | |||||||||
| Direct - U.S. and Canada | 297 | 329 | (9.7 | %) | 558 | 609 | (8.4 | %) | |||||||||||||
| International (b) | 89 | 86 | 2.2 | % | 147 | 169 | (13.1 | %) | |||||||||||||
| Total Bath & Body Works | $ | 1,526 | $ | 1,559 | (2.1 | %) | $ | 2,910 | $ | 2,955 | (1.5 | %) |
(a) Results include fulfilled buy online-pick up in store orders.
(b) Results include royalties associated with franchised stores and wholesale sales.
Total Company-operated Stores:
| Stores | Stores | ||||||||||
| 2/3/2024 | Opened | Closed | 8/3/2024 | ||||||||
| United States | 1,739 | 40 | (18 | ) | 1,761 | ||||||
| Canada | 111 | - | - | 111 | |||||||
| Total Bath & Body Works | 1,850 | 40 | (18 | ) | 1,872 |
Total Partner-operated Stores:
| Stores | Stores | ||||||||||
| 2/3/2024 | Opened | Closed | 8/3/2024 | ||||||||
| International | 454 | 25 | (13 | ) | 466 | ||||||
| International - Travel Retail | 31 | - | - | 31 | |||||||
| Total International | 485 | 25 | (13 | ) | 497 |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment